Skip to main content

Table 2 Serum concentrations of hormones before and during treatment

From: Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion

 

Before treatment

During treatment

 

FSH (UI/l)

LH (UI/l)

Ta (ng/ml)

AMH (pmol/l)

INB (pg/ml)

FSH (UI/l)

LH (UI/l)

T (ng/ml)

AMH (pmol/l)

INB (pg/ml)

Patients with CPHD

P1

0.4

0

0.06

103

5

18

1.2

1

264

55

P2

0.03

<0.1

0.02

675

100

21

2.9

1.4

1644

505

P3

0.61

0.7

0.02

1984

155

18

2

2.8

1040

544

Patients with IHH

P4

1

0.4

0.05

125

91

40

4.6

2.8

29

111

P5

0.8

0.1

0.04

595

73

24

4.7

3.3

565

401

P6

0.1

<0.1

0.05

250

5

41

5.4

3.86

666

287

P7

0.3

<0.1

0.02

665

64

32

4.6

3.9

668

514

P8

0.21

<0.1

0.07

270

14

59

9.5

9.6

890

530

Mean value

0.48

0.15

0.04

583

63.3

31b

4.4b

3.6b

721

368

Normal valuesc

0,2–4

0,5–7,1

0.52–4.8

251–679

254–513

0,2–4

0,5–7,1

0.5–4.8

251–679

254–513

  1. IHH isolated gonadotropin deficiency, CPHD Combined Pituitary Hormonal Deficits (CPHD), INB inhibin B
  2. T testosterone
  3. aTo convert T into SI unit (nmol/l), multiply by 3.47
  4. b p < 0.005 vs baseline values
  5. cRange of normal values taken from reference [18, 19]